Remsima®24BT (infliximab) 100 mg powder for concentrate for solution for infusion

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.

Patient Information Leaflet

Lodotra® tablets (modified release prednisone)

Patient Information Leaflet